Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-004773

CEO and Chairman sold 8,400 shares at an average $70.43 ($591,600)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
ROBINS CHAD M CEO and Chairman 2021-01-19 Sale −8,300 $70.42 $584,486 1,769,880 D: show line 1 in the form
ROBINS CHAD M CEO and Chairman 2021-01-19 Sale −100 $71.14 $7,114 1,769,780 D: show line 2 in the form
Open-market sales · 8,400 sh · avg $70.43 · $591,600
Loading xslF345X03/doc4.xml…